SIGA
SIGA TECHNOLOGIES INC
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$3.14
−0.95%Year over year
Reported trailing growth
- Revenue
- -70.1%
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -5.1%
- EBITDA
- -11.5%
- EBIT
- -17.8%
- Net income
- -11.8%
- EPS
- -10.5%
- Free cash flow
- +1.2%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026